Richard Appleton
Eaton Corporation
11 Papers
77 Citations
Richard Appleton is an academic researcher from Eaton Corporation. The author has contributed to research in topics: Epilepsy & Seizure types. The author has an hindex of 9, co-authored 11 publications.
Chat about Author
Papers
Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology
Claudia B. Catarino,Joan Liu,Ioannis Liagkouras,Vaneesha Gibbons,Robyn Labrum,Rachael Ellis,Cathy E. Woodward,Mary B. Davis,Shelagh J.M. Smith,J. Helen Cross,J. Helen Cross,Richard Appleton,Simone C. Yendle,Jacinta M McMahon,Susannah T. Bellows,Thomas S. Jacques,Thomas S. Jacques,Sameer M. Zuberi,Matthias J. Koepp,Lillian Martinian,Ingrid E. Scheffer,Ingrid E. Scheffer,Maria Thom,Sanjay M. Sisodiya +23 more
TL;DR: Evidence is provided that Dravet syndrome is at least in part an epileptic encephalopathy, and there was remarkable preservation of neurons and interneurons in the neocortex and hippocampi of DraveT adult post-mortem cases.
Living with a brother or sister with epilepsy: Siblings’ experiences
Annette Hames,Richard Appleton +1 more
TL;DR: This initial study suggests that siblings of children with epilepsy have many positive but also early negativefeelings, and specifically feelings of care and love for their sibling.
30
Effectiveness and tolerability of zonisamide in children with epilepsy: A retrospective review
TL;DR: Zonisamide appeared to be a reasonably effective and generally well-tolerated antiepileptic drug in a heterogeneous group of 57 children with poorly controlled epilepsy and provides another treatment option for children with refractory seizures.
24
Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy
Anand Iyer,Richard Appleton +1 more
TL;DR: A brief overview of the existing scientific literature around treatment options is provided and emerging newer treatment options in infantile spasms are outlined.
17
Sulthiame in refractory paediatric epilepsies: An experience of an ‘old’ antiepileptic drug in a tertiary paediatric neurology unit
Nina Swiderska,Daniel B Hawcutt,Victoria Eaton,Faye Stockton,Ram Kumar,Rachel Kneen,Richard Appleton +6 more
TL;DR: Sulthiame was reasonably effective and well-tolerated in a heterogeneous group of 20 children with refractory epilepsies and should be considered in a similar population.
17